Articles related to STEM CELLS

An updated review of multiple myeloma management highlights revised high-risk definitions, anti-CD38-based quadruplet induction regimens, evolving maintenance strategies, and increasing use of CAR-T and bispecific immunotherapies across the disease continuum.

To help patients and clinicians in strategizing about care decisions at the individual level, ASH convened a multidisciplinary panel — which included experts and patient representatives — to form standardized guidelines for newly diagnosed AML in older patients.

When hair turns gray, it may signal that the body has also avoided melanoma, as pigment-producing stem cells can either become depleted, which leads to hair graying, or multiply, depending on the kind of stress and signals in their environment.

Primary care physicians are crucial in managing the intricate health complications of allogeneic HCT survivors, including chronic graft-vs-host disease and increased cardiovascular risks.

Explore the latest insights into the complex pathophysiology of steroid-refractory cGVHD and the significant strides made in treatment options, including the impactful roles of ruxolitinib, belumosudil, and ibrutinib in enhancing patient outcomes.

In light of recent findings, CD24Fc emerges as a potential game-changer in preventing acute GVHD in HSCT patients, with a notable survival rate improvement to 96.2% for severe cases.